Establishing a reference range for bone turnover markers in young, healthy women

Bone

Volumn 42, Issue 4, 2008, Pages 623-630

  Glover, S J ^a   Garnero, P ^b,c   Naylor, K ^a   Rogers, A ^a   Eastell, R ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b INSERM   (France)

^c Synarc   (France)

Author keywords

Antiresorptive therapy; Bone turnover markers; Postmenopausal osteoporosis; Pre menopausal; Reference range

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; OSTEOCALCIN; PEPTIDE DERIVATIVE; PROCOLLAGEN TYPE I N PROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD; BODY MASS; BONE TURNOVER; CONTROLLED STUDY; CROSS LINKING; FEMALE; HUMAN; LIFESTYLE; MICTURITION; OVULATION; PREMENOPAUSE; QUESTIONNAIRE; SMOKING HABIT;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; FEMALE; HEALTH; HUMANS; MIDDLE AGED; REFERENCE VALUES;

EID: 40849102299     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.12.218     Document Type: Article

References (36)

1. Eastell R., Barton I., Hannon R.A., Chines A., Garnero P., and Delmas P.D. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18 (2003) 1051-1056
2. Wu X.P., Liao E.Y., Huang G., Dai R.C., and Zhang H. A comparison study of the reference curves of bone mineral density at different skeletal sites in native Chinese, Japanese, and American Caucasian women. Calcif Tissue Int 73 (2003) 122-132
3. Garnero P., Hausherr E., Chapuy M.C., Marcelli C., Grandjean H., Muller C., et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Mineral Res 11 (1996) 1531-1538
4. Garnero P., and Delmas P.D. [Biochemical markers of bone turnover: clinical usefulness in osteoporosis]. Ann Biol Clin (Paris) 57 (1999) 137-148
5. Gertz B.J., Shao P., Hanson D.A., Quan H., Harris S.T., Genant H.K., et al. Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res 9 (1994) 135-142
6. Garnero P., Shih W.J., Gineyts E., Kalpf D., and Delmas P.D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79 (1994) 1693-1700
7. Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., and Pak C.Y. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90 (2005) 1294-1301
8. Hannon R., and Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporos Int 11 6 (2000) S30-S44
9. Pi Y.Z., Wu X.P., Liu S.P., Luo X.H., Cao X.Z., Xie H., et al. Age-related changes in bone biochemical markers and their relationship with bone mineral density in normal Chinese women. J Bone Miner Metab 24 (2006) 380-385
10. Hoshino H., Kushida K., Takahashi M., Yamazaki K., Denda M., Atsumi K., et al. Changes in levels of biochemical markers and ultrasound indices of Os calcis across the menopausal transition. Osteoporos Int 11 (2000) 128-133
11. Karlsson R., Eden S., and von S.B. Oral contraception affects osteocalcin serum profiles in young women. Osteoporos Int 2 (1992) 118-121
12. Garnero P., Sornay-Rendu E., and Delmas P.D. Decreased bone turnover in oral contraceptive users. Bone 16 (1995) 499-503
13. Altman. Practical statistics for medical research (1991) 419-426
14. Evans C. Effects of low and high sodium diets on calcium metabolism in premenopausal and postmenopausal women (1993)
15. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol(Oxf) 62 (2005) 265-281
16. Garnero P., Sornay-Rendu E., Chapuy M.C., and Delmas P.D. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11 (1996) 337-349
17. Ebeling P.R., Atley L.M., Guthrie J.R., Burger H.G., Dennerstein L., Hopper J.L., et al. Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81 (1996) 3366-3371
18. Overlie I., Morkrid L., Andersson A.M., Skakkebaek N.E., Moen M.H., and Holte A. Inhibin A and B as markers of menopause: a five-year prospective longitudinal study of hormonal changes during the menopausal transition. Acta Obstet Gynecol Scand 84 (2005) 281-285
19. Perrien D.S., Achenbach S.J., Bledsoe S.E., Walser B., Suva L.J., Khosla S., et al. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone. J Clin Endocrinol Metab 91 (2006) 1848-1854
20. Burger H.G., Dudley E.C., Hopper J.L., Groome N., Guthrie J.R., Green A., et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 84 (1999) 4025-4030
21. al-Azzawi F. The menopause and its treatment in perspective. Postgrad Med J 77 (2001) 292-304
22. Melton III L.J., Khosla S., Atkinson E.J., O'Fallon W.M., and Riggs B.L. Relationship of bone turnover to bone density and fractures. J Bone Mineral Res 12 (1997) 1083-1091
23. Chiu K.M., Ju J., Mayes D., Bacchetti P., Weitz S., and Arnaud C.D. Changes in bone resorption during the menstrual cycle. J Bone Miner Res 14 (1999) 609-615
24. Henry Y.M., Fatayerji D., and Eastell R. Attainment of peak bone mass at the lumbar spine, femoral neck and radius in men and women: relative contributions of bone size and volumetric bone mineral density. Osteoporos Int 15 (2004) 263-273
25. Garnero P., Sornay-Rendu E., Claustrat B., and Delmas P.D. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Mineral Res 15 (2000) 1526-1536
26. Revilla M., Villa L.F., Sanchez-Atrio A., Hernandez E.R., and Rico H. Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int 61 (1997) 134-138
27. Rico H., Arribas I., Casanova F.J., Duce A.M., Hernandez E.R., and Cortes-Prieto J. Bone mass, bone metabolism, gonadal status and body mass index. Osteoporos Int 13 (2002) 379-387
28. Ricci T.A., Heymsfield S.B., Pierson Jr. R.N., Stahl T., Chowdhury H.A., and Shapses S.A. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am J Clin Nutr 73 (2001) 347-352
29. Reid I.R. Relationships among body mass, its components, and bone. Bone 31 (2002) 547-555
30. Di Carlo C., Tommaselli G.A., Gargouri A., Sammartino A., Bifulco G., Tauchmanova L., et al. Effects of estrogen-progestin therapy on serum levels of RANKL, osteoprotegerin, osteocalcin, leptin, and ghrelin in postmenopausal women. Menopause: J North Am Menopause Soc 14 (2007) 1
31. Bjarnason N.H., and Christiansen C. The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 85 (2000) 590-596
32. Gorai I., Taguchi Y., Chaki O., Kikuchi R., Nakayama M., Yang B.C., et al. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle. J Clin Endocrinol Metab 83 (1998) 326-332
33. Nielsen H.K., Lundby L., Rasmussen K., Charles P., and Hansen C. Alcohol decreases serum osteocalcin in a dose-dependent way in normal subjects. Calcif Tissue Int 46 (1990) 173-178
34. Green J.H., Booth C., and Bunning R. Acute effect of high-calcium milk with or without additional magnesium, or calcium phosphate on parathyroid hormone and biochemical markers of bone resorption. Eur J Clin Nutr 57 (2003) 61-68
35. Garcia-Sanchez A., Gonzalez-Calvin J.L., Diez-Ruiz A., Casals J.L., Gallego-Rojo F., and Salvatierra D. Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function. Alcohol Alcohol 30 (1995) 449-453
36. Heaney R.P. Is the paradigm shifting?. Bone 33 (2003) 457-465